id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-021770-zn7na974	Slifka, Mark K.	Passive Immunization	2017-07-17		.txt	text/plain	12134	610	31	[26] [27] [28] [29] Recent studies verify these earlier results, demonstrating a 90% to 91% vaccine efficacy against whooping cough among infants younger than 2 months of nonlymphoid tissues and to penetrate mucosal sites of infection is likely to explain why it is often considered the best immunoglobulin isotype for routine passive immunization and has shown clinical benefit ranging from reduced clinical symptoms to nearly complete protection from lethal infection in a number of infectious disease models (Table 8 .3). 118 With the recent development of polyclonal and monoclonal antibodies that show protective efficacy against tularemia in animal models, [119] [120] [121] it may be possible to incorporate both passive immunotherapy and antibiotic treatment into clinical practice not only for tularemia, but for other bacterial diseases, especially in cases in which antibiotic resistance is becoming more widespread.	./cache/cord-021770-zn7na974.txt	./txt/cord-021770-zn7na974.txt